Search clinical trials for: Saredutant

Total 13 results

Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder

Generalized Anxiety

United States, Australia
Sanofi

Completed

A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression

Depressive Disorder

United States
Sanofi

Completed

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

France, Canada, Germany, Portugal, Czech Republic, Mexico, Croatia, Chile
Sanofi

Completed

A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder

Anxiety

United States, Canada
Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

Canada, Germany, Portugal, Estonia, Mexico, Croatia, Chile, Czechia
Sanofi

Completed

A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

Depressive Disorder

United States
Sanofi

Completed

A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression

Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder

Depressive Disorder

United States, France, Russian Federation, Sweden, Turkey, Czech Republic, Mexico, Croatia
Sanofi

Completed

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder

Generalized Anxiety

France, Canada, Italy, Turkey, Finland, Sweden, Belgium
Sanofi

Completed

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

Major Depressive Disorder

United States, France, Sweden, Mexico, Argentina, Finland
Sanofi

Completed

An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder (COMPASS)

Depressive Disorder, Major

United States, Russian Federation, Germany, Estonia, Mexico, Korea, Republic of, Chile, South Africa

3

Subscribe